Business Context and Reporting Period
This Form 8-K is filed by Ipsidy Inc. (not Authid Inc.) with a report date of December 31, 2020. The filing discloses the entry into material definitive agreements regarding executive compensation and appointments effective May 22, 2020.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on executive compensation terms and equity grants.
Material Changes and Executive Appointments
- Executive Appointments: Phillip L. Kumnick was appointed Chief Executive Officer (CEO) and Philip R. Broenniman was appointed Chief Operating Officer (COO) and President, effective May 22, 2020.
- Compensation Adjustments:
- CEO (Kumnick): Base salary increased from $125,000 to $187,500 annually as of November 1, 2020. Potential increase to $250,000 upon achieving a revenue target of $8,000,000. Eligible for a bonus up to $64,980.
- COO (Broenniman): Base salary increased from $87,500 to $131,250 annually as of November 1, 2020. Potential increase to $175,000 upon achieving the revenue target. Eligible for a bonus up to $45,833.
- Equity Grants:
- CEO granted options for 33,333,334 shares of common stock.
- COO granted options for 16,666,666 shares of common stock.
- Vesting: 20% at grant; remainder subject to performance conditions.
Guidance, Outlook, and Risks
Performance Targets: Executive salary increases and bonuses are contingent upon the Company achieving a fiscal year revenue target of not less than $8,000,000.
Employment Terms: Both executives are employed on an "at-will" basis. Bonuses are also triggered by a change of control or involuntary termination.
Disclosure Note: The filing states that the summary is not complete and refers readers to the full agreements attached to the Annual Report on Form 10-K for complete terms.
Investor Verification Checklist
- Verify the Company's actual revenue for the fiscal year to determine if the $8,000,000 target was met, triggering salary increases and bonuses.
- Review the full text of the Offer Letters in the Form 10-K to understand specific performance conditions for the remaining equity vesting.
- Confirm the total number of authorized shares to assess the dilution impact of the 50,000,000 combined options granted.
- Check subsequent filings for any changes in executive status or compensation following the "at-will" employment terms.